相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor Infiltrating Lymphocytes in Ovarian Cancer
Maria Luisa Gasparri et al.
Asian Pacific Journal of Cancer Prevention (2015)
High STAT1 mRNA levels but not its tyrosine phosphorylation are associated with macrophage infiltration and bad prognosis in breast cancer
Piotr Tymoszuk et al.
BMC CANCER (2014)
Evidence for the antagonistic form of CXC-motif chemokine CXCL10 in serous epithelial ovarian tumours
Adam Rainczuk et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
IP-10/CXCL10 induction in human pancreatic cancer stroma influences lymphocytes recruitment and correlates with poor survival
Serena Lunardi et al.
ONCOTARGET (2014)
Prognostic Impact of Human Leukocyte Antigen Class I Expression and Association of Platinum Resistance with Immunologic Profiles in Epithelial Ovarian Cancer
Tasuku Mariya et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies
F. Bellati et al.
CURRENT MOLECULAR MEDICINE (2013)
Monoclonal antibodies therapies for ovarian cancer
Umberto Leone Roberti Maggiore et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Interaction between treg cells and angiogenesis: A dark double track
Maria Luisa Gasparri et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Serum CXCL9 Levels Are Associated with Tumor Progression and Treatment Outcome in Patients with Nasopharyngeal Carcinoma
Li-Jen Hsin et al.
PLOS ONE (2013)
Mammary Carcinoma Cell Derived Cyclooxygenase 2 Suppresses Tumor Immune Surveillance by Enhancing Intratumoral Immune Checkpoint Activity
Nune Markosyan et al.
BREAST CANCER RESEARCH (2013)
A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study
A. K. L. Reyners et al.
ANNALS OF ONCOLOGY (2012)
The Next Challenge in Cancer Immunotherapy: Controlling T-Cell Traffic to the Tumor
Jean-Pierre Abastado
CANCER RESEARCH (2012)
CXCR3+ T Regulatory Cells Selectively Accumulate in Human Ovarian Carcinomas to Limit Type I Immunity
Nassima Redjimi et al.
CANCER RESEARCH (2012)
NF-κB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells
Ravikumar Muthuswamy et al.
CANCER RESEARCH (2012)
Current knowledge and open issues regarding Bevacizumab in gynaecological neoplasms
Filippo Bellati et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
Combination strategies to enhance antitumor ADCC
Holbrook E. Kohrt et al.
IMMUNOTHERAPY (2012)
Monoclonal antibodies for the treatment of cancer
Casey W. Shuptrine et al.
SEMINARS IN CANCER BIOLOGY (2012)
Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer
Holger Bronger et al.
BREAST CANCER RESEARCH (2012)
Immunotherapy for Ovarian Cancer: What's Next?
Lana E. Kandalaft et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
TNFα and IFNγ Synergistically Enhance Transcriptional Activation of CXCL10 in Human Airway Smooth Muscle Cells via STAT-1, NF-κB, and the Transcriptional Coactivator CREB-binding Protein
Deborah L. Clarke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
Carsten Denkert et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
Ilona Kryczek et al.
BLOOD (2009)
Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy
Katja Specht et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss
Blaise Clarke et al.
MODERN PATHOLOGY (2009)
Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expression
Min Liu et al.
MODERN PATHOLOGY (2009)
Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 Ligands
Marco Wendel et al.
CANCER RESEARCH (2008)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma
Marketa Tomsova et al.
GYNECOLOGIC ONCOLOGY (2008)
Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis
Mitsuko Furuya et al.
HUMAN PATHOLOGY (2007)
CXC chemokine ligand 9/monokine induced by IFN-γ production by tumor cells is critical for T cell-mediated suppression of cutaneous tumors
Anton V. Gorbachev et al.
JOURNAL OF IMMUNOLOGY (2007)
Targeted in vivo expression of IFN-γ-inducible protein 10 induces specific antitumor activity
Xiuli Yang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Cycloxygenase-2 inhibition augments the efficacy of a cancer vaccine
AR Haas et al.
CLINICAL CANCER RESEARCH (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier
H Bronger et al.
CANCER RESEARCH (2005)
Cyclooxygenase inhibitors modulate NK activities that control metastatic disease
N Kundu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Cyclooxygenase 2 inhibition promotes IFN-γ-dependent enhancement of antitumor responses
S Sharma et al.
JOURNAL OF IMMUNOLOGY (2005)
Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer
T Daikoku et al.
CANCER RESEARCH (2005)
Up-regulation of the interferon γ (IFN-γ)-inducible chemokines IFN-inducible T-Cell α chemoattractant and monokine induced by IFN-γ and of their receptor CXC receptor 3 in human renal cell carcinoma
T Suyama et al.
CANCER (2005)
High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma
T Kondo et al.
JOURNAL OF UROLOGY (2004)
Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise
AJ Dannenberg et al.
CANCER CELL (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma
C Denkert et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
分享论文
